Harjunpää, A <br/><br/>
Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma.  [electronic resource] 

 -  Leukemia & lymphoma  Aug 2001 
 - 731-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1042-8194 
<br/><br/><label>Standard No.: </label>10.3109/10428190109099335  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Blood Circulation--immunology<br/>Blood-Brain Barrier<br/>Central Nervous System--immunology<br/>Cerebrospinal Fluid--chemistry<br/>Complement Activation--drug effects<br/>Complement C3a--analogs & derivatives<br/>Humans<br/>Lymphoma, B-Cell--cerebrospinal fluid<br/>Male<br/>Middle Aged<br/>Rituximab